Open AccessCOST-EFFECTIVENESS OF POLYPILL TREATMENT IN HIGH-RISK HYPERTENSIVE SUBJECTS WITH HYPER-CHOLESTEROLAEMIA
Author(s) -
Alberto Mazza,
Gianni Bregola,
Enrico Cavazzin,
Fabio Dell’avvocata,
Massimo Giordan,
Gianluca Rigatelli,
Marinella Rosini,
Bruno Bignardi,
Antonio Bragiotto,
Tiziano Crino,
Gabriella Chieregato,
Roberto Fante,
Mauro Favaron,
Matteo Lazzarin,
Ettore Petracca,
Michele Roccato,
Silvia Sartorello,
G Scanavacca,
Maria Lucia Zaramella,
Stefano Cuppini
Publication year - 2022
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000837684.48681.27
Subject(s) - medicine , polypill , amlodipine , rosuvastatin , hydrochlorothiazide , atorvastatin , valsartan , blood pressure , fixed dose combination , candesartan , pharmacology , ramipril , perindopril , telmisartan , enalapril , combination therapy , atenolol , lercanidipine , angiotensin ii , angiotensin converting enzyme , aspirin